{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:19:56Z","timestamp":1758925196135},"reference-count":5,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1536\/ihj.16-040","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T22:06:07Z","timestamp":1463090767000},"page":"389-390","source":"Crossref","is-referenced-by-count":4,"title":["Everolimus-Incorporated Therapy Reduces Myocardial Hypertrophy in Recipients of Heart Transplantation"],"prefix":"10.1536","volume":"57","author":[{"given":"Teruhiko","family":"Imamura","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Amiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hirt SW, Bara C, Barten MJ, <i>et al<\/i>. Everolimus in heart transplantation: an update. J Transplant 2013; 2013: 683964.","DOI":"10.1155\/2013\/683964"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Imamura T, Kinugawa K, Nitta D, Kinoshita O, Nawata K, Ono M. Everolimus attenuates myocardial hypertrophy and improves diastolic function in heart transplant recipients. Int Heat J 2016; 57: 198-204.","DOI":"10.1536\/ihj.15-332"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Buss SJ, Muenz S, Riffel JH, <i>et al<\/i>. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol 2009; 54: 2435-46.","DOI":"10.1016\/j.jacc.2009.08.031"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Soesanto W, Lin HY, Hu E, <i>et al<\/i>. Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 2009; 54: 1321-7.","DOI":"10.1161\/HYPERTENSIONAHA.109.138818"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Xu X, Roe ND, Weiser-Evans MC, Ren J. Inhibition of mammalian target of rapamycin with rapamycin reverses hypertrophic cardiomyopathy in mice with cardiomyocyte-specific knockout of PTEN. Hypertension 2014; 63: 729-39.","DOI":"10.1161\/HYPERTENSIONAHA.113.02526"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/3\/57_16-040\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:34:25Z","timestamp":1498311265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/3\/57_16-040\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-040","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}